Baker P, Knoblock K, Noll L, Wyatt D, Lydersen B
Dev Biol Stand. 1985;60:63-72.
KC 2000 TM is a serum-free medium designed and developed for use in all phases of hybridoma technology providing maximum growth and antibody production. This unique medium provides consistent results as its performance is not affected by variation found in serum. In addition, the use of KC 2000 TM reduces the risk of contamination of cultures by mycoplasma and viruses which may be present in low concentrations in serum. Antibody production and assays are performed in KC 2000 TM without high concentrations of interfering proteins. Only those proteins necessary to produce maximum performance in all hybridoma applications are present (250 micrograms protein/ml). Extensive testing has shown that this serum-free medium yields maximum results in all aspects of hybridoma technology, including the generation of antibody secreting hybridomas, as well as their subcloning. With a single exception, all cell lines tested could be transferred directly from medium containing serum into KC 2000 TM. Consistent growth and antibody production was maintained during subsequent passaging of these cells. These results show that KC 2000 TM is unique among serum-free media as it is the only serum-free medium that can be successfully utilized in the selection of HAT-resistant hybrid cell clones after use of a single type of medium throughout the entire process of development and maintenance of hybridoma cell lines.
KC 2000 TM是一种无血清培养基,专为杂交瘤技术的各个阶段设计和开发,可实现最大程度的生长和抗体产生。这种独特的培养基提供一致的结果,因为其性能不受血清中发现的变化影响。此外,使用KC 2000 TM可降低支原体和病毒污染培养物的风险,这些支原体和病毒可能以低浓度存在于血清中。抗体产生和检测在KC 2000 TM中进行,无需高浓度的干扰蛋白。仅存在在所有杂交瘤应用中产生最大性能所必需的那些蛋白质(250微克蛋白质/毫升)。广泛的测试表明,这种无血清培养基在杂交瘤技术的各个方面都能产生最大的效果,包括产生分泌抗体的杂交瘤及其亚克隆。除了一个例外,所有测试的细胞系都可以直接从含血清的培养基转移到KC 2000 TM中。在这些细胞随后的传代过程中,保持了一致的生长和抗体产生。这些结果表明,KC 2000 TM在无血清培养基中是独特的,因为它是唯一一种在杂交瘤细胞系的整个开发和维持过程中使用单一类型培养基后,可成功用于选择抗HAT杂交细胞克隆的无血清培养基。